Challenges and recommendations for the management of asthma in the Middle East and Africa

Abstract

Clinical presentation of asthma is variable, and its diagnosis can be a major challenge in routine health-care practice, especially in low-and-middle-income countries. The aim of asthma management is to achieve optimal asthma control and to reduce the risk of asthma exacerbations and mortality. In the Middle East and in Africa (MEA), several patient- and physician-related factors lead to misdiagnosis and suboptimal management of asthma. A panel of experts comprising of specialists as well as general health-care professionals met to identify challenges and provide recommendations for the management of asthma in MEA. The major challenges identified for diagnosis of asthma were lack of adequate knowledge about the disease, lack of specialized diagnostic facilities, limited access to spirometry, and social stigma associated with asthma. The prime challenges for management of asthma in MEA were identified as overreliance on short-acting β-agonists (SABAs), underprescription of inhaled corticosteroids (ICS), nonadherence to prescribed medications, and inadequate insurance coverage for its treatment. The experts endorsed adapting the Global Initiative for Asthma guidelines at country and regional levels for effective management of asthma and to alleviate the overuse of SABAs as reliever medications. Stringent control over SABA use, discouraging over-the-counter availability of SABA, and using as-needed low-dose ICS and formoterol as rescue medications in mild cases were suggested to reduce the overreliance on SABAs. Encouraging SABA alone-free clinical practice in both outpatient and emergency department settings is also imperative. We present the recommendations for the management of asthma along with proposed regional adaptations of international guidelines for MEA.

Barriers to childhood asthma care in sub-Saharan Africa: a multicountry qualitative study with children and their caregivers

“…This is further seen with the low levels of inhaled corticosteroids (6.7–17%) and 73% of doctor-diagnosed/suspected asthma not using any inhaler documented 6 31. Over-reliance on short-acting beta agonist inhalers per se is also a barrier to appropriate care 32. A preference for oral over inhaler-administered medications and widely held concerns that metred dose inhalers were addictive and harmful identified have been noted previously 10 18.…”

Identifying health research in the era of COVID-19: A scoping review

“…42 In addition, another study discussed the recommendations for the management of asthma along with regional adaptations of international guidelines for the MENA. 43 Patients with both types of diseases were interviewed to assess the technical use of pressurized metered dose inhalers and it was shown that many patients with respiratory diseases were not properly using their medications which requires intervention of their healthcare professionals. 44 Studies that focused on mental/psychological health COVID-19 restriction measures, such as social isolation, have affected the mental and psychological wellbeing of millions of people worldwide.…”

Global Trends in Therapy of Patients with Bronchial Asthma — a Personalized Approach to Treatment

“…Через 3 місяці після впровадження експертних рекомендацій вдалось знизити число призначень монотерапії БАКД на 40 % та на 20 % збільшити число призначень комбінації ІКС-формотерол. І такі зміни, в свою чергу, призвели до збільшення на 55 % числа пацієнтів з контрольованою астмою та до зниження на 35 % числа пацієнтів, що потребували невідкладної допомоги [25][26][27][28][29].…”